Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of "Buy" by Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) have been assigned an average rating of "Buy" from the seventeen research firms that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $24.88.

A number of research analysts have weighed in on PRVA shares. Stephens reissued an "overweight" rating and issued a $26.00 target price on shares of Privia Health Group in a report on Thursday, January 2nd. Barclays raised their price objective on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a report on Friday, November 8th. KeyCorp initiated coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an "overweight" rating and a $23.00 target price for the company. Truist Financial lifted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Finally, JPMorgan Chase & Co. raised their target price on Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a report on Friday, November 29th.

Institutional Investors Weigh In On Privia Health Group

Hedge funds have recently made changes to their positions in the company. Canada Pension Plan Investment Board purchased a new stake in shares of Privia Health Group during the 2nd quarter worth approximately $26,000. GAMMA Investing LLC increased its holdings in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after buying an additional 845 shares during the last quarter. Quarry LP raised its position in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. KBC Group NV lifted its holdings in shares of Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company's stock valued at $62,000 after acquiring an additional 871 shares during the last quarter. Finally, Neo Ivy Capital Management purchased a new position in Privia Health Group in the third quarter worth about $66,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA traded up $0.63 during midday trading on Wednesday, hitting $20.93. 383,371 shares of the stock traded hands, compared to its average volume of 561,614. The firm has a market capitalization of $2.51 billion, a P/E ratio of 209.32, a PEG ratio of 5.45 and a beta of 0.85. Privia Health Group has a one year low of $15.92 and a one year high of $23.78. The firm has a 50-day moving average of $20.80 and a two-hundred day moving average of $19.38.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.